The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate
- 31 October 1991
- journal article
- clinical trial
- Published by Elsevier in Bone and Mineral
- Vol. 15 (1) , 73-81
- https://doi.org/10.1016/0169-6009(91)90111-c
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- PREVENTION OF STEROID-INDUCED OSTEOPOROSIS WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (APD)The Lancet, 1988
- Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humansCalcified Tissue International, 1984
- Effect of oral 1,25‐dihydroxyvitamin D and calcium on glucocorticoid‐induced osteopenia in patients with rheumatic diseasesArthritis & Rheumatism, 1984
- Glucocorticoid-Induced OsteoporosisNew England Journal of Medicine, 1983
- INFLUENCE OF 1α‐(OH)D3 ADMINISTRATION ON BONE AND BONE MINERAL METABOLISM IN PATIENTS ON CHRONIC GLUCOCORTICOID TREATMENT; A DOUBLE BLIND CONTROLLED STUDYClinical Endocrinology, 1983
- Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapyMetabolism, 1983
- The effects of sex steroid and corticosteroid hormones on boneJournal of Steroid Biochemistry, 1981
- Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration.Journal of Clinical Investigation, 1979
- Microcrystalline calcium hydroxyapatite compound in corticosteroid-treated rheumatoid patients: a controlled study.BMJ, 1978
- BONE FORMATION IN HYPERCORTISONISMActa Endocrinologica, 1970